In Vivo Selection of Streptococcus pneumoniae, Resistant to Quinolones, Including Sparfloxin-Reference-Cited by-同舟云学术

In Vivo Selection of Streptococcus pneumoniae, Resistant to Quinolones, Including Sparfloxin

Published:1995-09 Issue:1 Volume:1 Page:60-61
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Bernard Louis,Nguyen Van Jean-Claude,Mainardi Jean-Luc

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference5 articles.

1. Pneumococcal resistance to antibiotics;Klugman;Clinical Microbiology Review,1990

2. Comparative in vitro activities of sparfloxacin (CI-978; AT-4140 and other antimicrobial agents against staphylococci, enterococci, and respiratory tract pathogens;Simor;Antimicrob Agents Chemother,1990

3. Epidémiologie de la résistance aux antibiotiques de Streptococcus pneumoniae en France (1984–1993);Geslin;Médecine et Maladie Infectieuse,1994

4. Induction of resistance of Streptococcus pneumoniae to quinolones in vitro;Lafredo;Chemotherapy,1993

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global Transcriptome Analysis of the Responses of a Fluoroquinolone-Resistant Streptococcus pneumoniae Mutant and Its Parent to Ciprofloxacin;Antimicrobial Agents and Chemotherapy;2006-01

2. Genetic Analyses of Mutations Contributing to Fluoroquinolone Resistance in Clinical Isolates of Streptococcus pneumoniae;Antimicrobial Agents and Chemotherapy;2001-12

3. New Mutation in ParE in a Pneumococcal In Vitro Mutant Resistant to Fluoroquinolones;Antimicrobial Agents and Chemotherapy;2001-03

4. Activities of Clinafloxacin, Gatifloxacin, Gemifloxacin, and Trovafloxacin against Recent Clinical Isolates of Levofloxacin-Resistant Streptococcus pneumoniae;Antimicrobial Agents and Chemotherapy;2000-11

5. Activities of Newer Fluoroquinolones against Streptococcus pneumoniae Clinical Isolates Including Those with Mutations in the gyrA , parC , and parE Loci;Antimicrobial Agents and Chemotherapy;1999-02